IGNT: Investor requests help with DD
Diffferent Bill
***FYI: Medox is Ingen's largest (only) customer AND is Ingen's 2nd largest shareholder--BillFW**
finance.google.com
From Google Groups:
More Medox info, or lack therof
8169. Bill View profile
More options Nov 11, 7:10 pm
Hi all,
I have posted a couple of times regarding my distrust of the PR's
stating sales of Oxyviews to Medox, so just now I tried very hard to
get contact information for Medox. As you may have read in one of my
earlier posts, the address listed on Lyons in Newhall is a Mail Boxes,
Etc.
Searching for Medox Corporation, of course, gives tons of hits for the
wrong companies, but adding Lyons or Newhall to the search terms, and
the ONLY hits that come up are related to Ingen. Imagine a medical
supply company with no website, and no internet hits except in
relation to one supplier. Then, I found in an SEC filing from IGNT
the following phone number for Medox: (661) 510-3559
First I did a reverse phone lookup, and found that it was a cell phone
that was unpublished. Then I called it, and it was answered,
"Hello?" I said that I might have the wrong number, as I was looking
for Medox. He said, "This is Medox, how can I help you?" I told him
I was doing due diligence on Ingen, and was researching whether Medox
was indeed a legitimate Medical Supply Company, and mentioned how hard
I had to work to find a phone number. He said "This is a private
company." I asked if they sell any other products besides Oxyview and
he said that they sell many different products. I asked if they have
a warehouse and he said yes they do, in Los Angeles. I asked for the
address and he refused to give it to me. I asked who he sells to, and
he said he wouldn't divulge his client list. I told him that when
calling a medical supply company and having the phone answered,
"Hello", didn't inspire much confidence that the company was real. He
said, "Well, you caught me off guard." I hung up.
In my opinion, there is no way that a legitimate medical supply
company can exist without an easily obtainable phone number, some
level of promotion so that customers know it exists, and some kind of
internet presence when searching for it. This is a scam perpetrated
by Scott Sand and Jeff Gleckman to give the appearance of legitimate
business.
I would welcome anyone who can provide information that shows that
Medox is actually conducting Medical Supply business. Try the phone
number. It's probably Gleckman who answered, but I didn't ask his
name. Let's see how long before the number is disconnected
reuters.com
YUCAIPA, Calif., Nov. 4, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink
Sheets:IGNT), a leading global Medical Device Manufacturer focused on the $4B
Respiratory market with their Oxyview products for the growing aging population
and emerging markets for Home (DME), Hospital and Aviation industries, announced
today that the company has received a purchase order from MedOx Corporation for
40,000 new Oxyview Nasal Cannulas in value of $100,000.
globenewswire.com
YUCAIPA, Calif., July 17, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), a leading Medical Device Manufacturer focused in the $8 Billion global Respiratory Markets for the growing aging population and emerging markets for Home (DME), Hospital and Aviation Industries, announced today that the company has received a purchase order from MedOx Corporation for 40,000 Oxyview-Nasal Cannulas.
pinksheets.com
Of our sales in the current quarter, $100,000 of sales were from one
customer, Medox Corporation, with whom we have entered into other transactions, including
sales of Series A preferred stock to both Medox and its President. We had also previously issued
to Medox convertible debentures on June 1, 2004 for $225,000 and March 15, 2007 for $200,000
in consideration for services rendered to the Company in assisting with its sales and marketing of
Oxyview. These notes were converted into common stock and paid in full in 2009 (the Company
has issued 515,040,412 shares of its common stock to retire these obligations). As of October 13,
2009, Mr. Gleckman directly or indirectly (through Medox Corporation) owned 125,008,851
shares of our common stock (4.45% of the outstanding shares of common stock) and 2,500,00
shares of our Series A preferred stock (2.62% of the outstanding shares of preferred stock). |
